Online Remote Monitoring of Patients with Differentiated Thyroid Carcinomas and Neuroendocrine Tumors Treated with High Doses of Radionuclides

Matović, Milovan; Janković, Slobodan; Jeremic, Marija; Vlajković, Marina; Matović, Vesna

doi:10.1089/tmj.2011.0105

Cited by 2 publications

(2 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In our previous study we presented a telemedicine system that enables video surveillance of the RA and telemonitoring of the patients' vital functions following the administration of radioiodine. 6 This experience prompted our decision to upgrade the previous system and enable it to measure the exposure rate online, in real time, during the entire hospitalization period.…”

Section: Discussionmentioning

confidence: 99%

THYRPAN-TM Prototype: New System for Online Telemonitoring of Patients with Thyroid Carcinoma During the Treatment with a High Dose of Radioiodine

Matović

Jeremic

Janković

et al. 2015

Telemedicine and e-Health

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

THYRPAN-TM Prototype: New System for Online Telemonitoring of Patients with Thyroid Carcinoma During the Treatment with a High Dose of Radioiodine

Matović

Jeremic

Janković

et al. 2015

Telemedicine and e-Health

Self Cite

View full text Add to dashboard Cite

show abstract

“…Based on our pre vi ous ex pe ri ence [11,12], we have de cided to use a telemedicine ap proach as a so lution for this chal lenge. The aim of this pa per was to pres ent key fea tures of our in no va tive alarm ing sys tem.…”

Section: Introductionmentioning

confidence: 99%

Alarm system for surveillance of patients receiving high doses of radioiodine (131I) therapy in the case of unauthorised abandoning of a controlled area

et al. 2018

Self Cite

View full text Add to dashboard Cite

Af ter re ceiv ing high doses of radioiodine the pa tients have to re main iso lated within the "restricted area", un til the ra dio ac tiv ity of the body drops be low a cer tain level. The aim of this pa per was to pres ent our alarm ing sys tem de signed to dis cover pa tients who at tempt to abandon the "re stricted area" and in form med i cal staff about the event. The sys tem con sists of a sur vey-me ter with a pan cake probe di rected to wards the cor ri dor. The sur vey-me ter is connected to a trig ger cir cuit which gives a sig nal in the case when the mea sured count rate exceeds a pre-set value. This sig nal sets "on" the alarm de vice, blink ing light, pro gram ma ble siren and IP cam era, in or der to warn the pa tient and in form the per son nel when such a case oc curs. In or der to test the con sis tency and sen si tiv ity of our sys tem we mea sured ten times the am bi ent dose equiv a lent, H * (10), from the source of 925 MBq (25 mCi) 131 I, kept at a dis tance of 1 m. The av er age am bi ent dose equiv a lent was 77.73 ± 31.57 (0.084 mSvh-1 per MBq, or 3.1 mSvh-1 per mCi). We mea sured ten times the same source at var i ous dis tances (1-2.25 m) from the probe. In each po si tion, the sys tem was trig gered. Also we tested the system on 40 pa tients treated with radioiodine in structed to pass through the cor ri dor. Each of their at tempts trig gered the sys tem. Ac cord ing to our ex pe ri ence gained over the past few years, this alarm sys tem in tended for pa tients re ceiv ing radionuclide ther apy en sures a high level of safety for both the pa tients and med i cal staff.

show abstract

Online Remote Monitoring of Patients with Differentiated Thyroid Carcinomas and Neuroendocrine Tumors Treated with High Doses of Radionuclides

Abstract: From our experience gained over the past 3 years, this model of organization and supervision with a telemonitoring system of patients receiving radionuclide therapy ensures a high level of safety for the patient, with significant reduction of staff costs.

Cited by 2 publications

References 31 publications

THYRPAN-TM Prototype: New System for Online Telemonitoring of Patients with Thyroid Carcinoma During the Treatment with a High Dose of Radioiodine

THYRPAN-TM Prototype: New System for Online Telemonitoring of Patients with Thyroid Carcinoma During the Treatment with a High Dose of Radioiodine

Alarm system for surveillance of patients receiving high doses of radioiodine (131I) therapy in the case of unauthorised abandoning of a controlled area

Contact Info

Product

Resources

About